Kalo­Bios binds up Mar­tin Shkre­li and cages his stock in a long good­bye

The new CEO at Kalo­Bios has al­ready made it clear that he doesn’t want to see Mar­tin Shkre­li play­ing new games with the com­pa­ny’s stock. Now, just to make sure that can nev­er hap­pen, he’s pro­vid­ed some le­gal rope and duct tape to keep the in­dict­ed biotech ex­ec and one-time hedge fund prankster safe­ly un­der wraps and out of sight.

CEO Cameron Dur­rant, who’s brought the com­pa­ny out of bank­rupt­cy and is now try­ing to blaze a new path for­ward, struck a deal that re­stricts Shkre­li’s han­dling of the stock he has left in Kalo­Bios. This new pact re­stricts his right to sell stock, of­fers Kalo­Bios a first right of re­fusal for any sale of the stock, and pro­hibits Shkre­li for trans­fer­ring the stock to any of his as­so­ciates.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.